Dashboards for Clinician Monitoring of Patients Through a Mobile Sensing Platform

Not Applicable

Completed

• Conditions: Behavioral Health With Medical Comorbidities
• Interventions: Other: Cogito Companion Intervention; Device: mobile phone application

• Registration Number: NCT02167373
• Lead Sponsor: Cogito Health Inc

Brief Summary

The purpose of this study is to determine whether the use of a mobile sensing platform in a primary care setting has an effect on provider workflows, patient outcomes, patient engagement, patient self-help behavior, health research, and total cost of care.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2014-06-03
• Study First Submitted QC: 2014-06-18
• Study First Posted: 2014-06-19
• Study Start: 2015-11
• Primary Completion: 2017-08-31
• Study Completion: 2017-09-30
• Status Verified: 2018-07
• Last Update Submitted: 2018-07-16
• Last Update Posted: 2018-07-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 171

Inclusion Criteria

• Be between 18 and 70 years of age.
• Speak, understand, and read conversational English.
• Be a current patient of South Huntington Clinic recommended for behavioral health care.
• Have a smartphone and cell service plan, including voice and data, that meets the device requirements of the Mobile Sensing Platform.

Exclusion Criteria

• Planning on permanently leaving Boston during the study period.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention	mobile phone application	Cogito Companion Intervention. Participants will be provided with a mobile phone application that provides feedback on their mental health. The participants' clinicians will be provided with a desktop application to review their patients' results.
Intervention	Cogito Companion Intervention	Cogito Companion Intervention. Participants will be provided with a mobile phone application that provides feedback on their mental health. The participants' clinicians will be provided with a desktop application to review their patients' results.

Primary Outcome Measures

Name	Time	Method
Treatment Outcome	Change from baseline to six months later	Depression will be assessed by the Patient Health Questionnaire-8.
Quality of Life Outcome	Change from baseline to six months later	Patient reported Schwartz Outcome Scale-10 (SOS-10).

Secondary Outcome Measures

Name	Time	Method
Cost of Care	Measured at six months	Cost of care can be measured by proxy, through counts of emergency room visits, hospitalization admissions and days, and hospital re-admissions in the last six months.
Self-Help Behavior	Measured at six months	Self-help behavior will be measured through change in behavior patterns, usage of the mobile application, and requests for additional resources in the last six months.
Patient Engagement	Measured at six months	Patient engagement will be assessed through frequency of patient use of the mobile technology, no-show rate at appointments, and completion of treatment homework assignments in the last six months.
Clinical Outcome (GAF)	Change from baseline to six months later	We will use the Global Assessment of Functioning (GAF) to measure overall functioning.

Trial Locations

Locations (1)

South Huntington Clinic; 🇺🇸 Jamaica Plain, Massachusetts, United States